Search

Reset

Searching with a thematic focus on Trade Policy, Intellectual Property Rights in India

Showing 11-20 of 42 results

Pages

  • Document

    India’s trade in drugs and pharmaceuticals: emerging trends, opportunities and challenges

    Research and Information System for Developing Countries, 2009
    It was argued in the context of economic reforms in pharmaceuticals sector, particularly in the context of changing patent regime, that growth in exports would be restricted, imports would get a fillip and balance of trade would be adversely affected. The paper looks into the recent experience in exports and imports of drugs and pharmaceutical products.
  • Document

    Towards a more equitable outcome from Rio plus 20

    Research and Information System for Developing Countries, 2012
    The “Rio plus 20” summit being held on 20-22 June 2012 provides an opportunity to launch a process for forging a new global compact, underpinned by greater equity and policy space for the developing countries, for dealing with sustainable development in an integrated and holistic fashion, and for moving away from the ‘silo’-mentality.
  • Document

    Prepare for new environmental standards in the global textile value chain

    2013
    This paper reflects the outcome of a study about environmental standards and their trade impacts – the case of Indian textiles and clothes (T&C) eco-labels in Nordic markets. The paper highlights that there is a substantial consumer pressure in Norway for more sustainable and eco-friendly solutions or eco-labels in particular.
  • Document

    Using TRIPS flexibilities to improve access to HIV treatment

    Joint United Nations Programme on HIV/AIDS, 2011
    This policy brief describes how the flexibilities contained in the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement and reaffirmed by the Doha Declaration provide important opportunities for World Trade Organization (WTO) Members to reduce prices and expand access to HIV medicines.
  • Document

    Intellectual property and access to clean energy technologies in developing countries: an analysis of solar photovoltaic, bio fuel and wind technologies

    Trade and Environment, 2007
    This paper explores whether developing countries will face barriers accessing technologies in reducing their emissions of greenhouse gases. Focusing on intellectual property rights (IP), it concentrates on the more scientifically advanced developing countries such as Brazil, China, and India.
  • Document

    A case study to show how TRIPS-plus intellectual property rules affect access to medicines

    Community Health Cell, Society for Community Health Awareness, Research and Action, 2007
    This document contains 3 separate papers dealing with the issue of “data exclusivity”, a term that refers to new “TRIPS-plus” measures that some governments, especially the US, are seeking to include in bilateral and regional trade agreements.
  • Document

    Protecting community rights over traditional knowledge: implications of customary laws and practices

    International Institute for Environment and Development, 2006
    This collaborative research project seeks to assist indigenous and local communities I protecting their rights over traditional knowledge (TK) relating to biological resources, in accordance with their customary laws and practices. The project further aims to inform and influence policy makers at all levels.
  • Document

    Farmers' rights in India: a case study

    Fridtjof Nansen Institute, 2006
    India is among the first countries in the world to have passed Farmers’ Rights and plant variety protection legislation. This study analyses the achievements, barriers and limitations of India’s approach so far.
  • Document

    Finally a drug that stimulates discovery!

    IPFrontline, 2005
    This magazine opinion piece describes how India is poised to become a global R&D leader with the introduction of product patent regime amidst fears from global world that Indian pharmaceutical is doomed.
  • Document

    What is Indian pharma's next move?

    IPFrontline, 2005
    This article describes how Indian pharmaceutical companies can emerge as a global R&D leader in the post product patent regime by patenting some of herbal formulations, in which India has significant experience.It outlines how most companies in the Indian pharmaceutical industry were able to register significant growth until 2005 because of a system of 'process patents' as against the Western c

Pages